Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Kim Boesen; Pia Brandt Danborg; Peter C. Gøtzsche; Karsten Juhl Jørgensen

doi:10.1002/14651858.CD012857

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Kim Boesen^*
, Pia Brandt Danborg
, Peter C. Gøtzsche
, Karsten Juhl Jørgensen

^*Corresponding author for this work

Rigshospitalet
Nordic Cochrane Centre

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of extended-release formulations of methylphenidate in adults diagnosed with ADHD.

Original language	English
Article number	CD012857
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	11
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD012857
Publication status	Published - 15. Nov 2017
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Documents & Links

10.1002/14651858.CD012857

SDU Link

Check access to the material in SDU Library's search engine

Cite this

@article{5bc21f888b5841d889a9c43aefb3ad82,

title = "Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of extended-release formulations of methylphenidate in adults diagnosed with ADHD.",

author = "Kim Boesen and Danborg, \{Pia Brandt\} and G{\o}tzsche, \{Peter C.\} and J{\o}rgensen, \{Karsten Juhl\}",

note = "Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2017",

month = nov,

day = "15",

doi = "10.1002/14651858.CD012857",

language = "English",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "11",

}

TY - JOUR

T1 - Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

AU - Boesen, Kim

AU - Danborg, Pia Brandt

AU - Gøtzsche, Peter C.

AU - Jørgensen, Karsten Juhl

PY - 2017/11/15

Y1 - 2017/11/15

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of extended-release formulations of methylphenidate in adults diagnosed with ADHD.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of extended-release formulations of methylphenidate in adults diagnosed with ADHD.

U2 - 10.1002/14651858.CD012857

DO - 10.1002/14651858.CD012857

M3 - Journal article

AN - SCOPUS:85034068814

SN - 1469-493X

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD012857

ER -

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Abstract

Bibliographical note

Documents & Links

SDU Link

Fingerprint

Cite this